Venture capital firm Accel just raised an impressive $5 billion in fresh funding to keep placing massive bets on artificial intelligence. The firm is well known for backing massive tech winners early on and already holds stakes in popular artificial intelligence companies like Anthropic, Cursor, and Perplexity. Now, it wants to spend this new capital to capture more of the booming tech market.
Most of the new capital targets established late-stage startups
Out of the total pool, $4 billion will go directly into Accel’s fifth Leaders fund. This specific fund focuses on writing large checks to established tech startups around the world. The company plans to make roughly 20 to 25 investments from this pool, with an average check size of around $200 million.
Don’t miss the best of The Mac Observer
Set us as a preferred source and our Apple reporting ranks higher in your Google Search results and Discover feed — one tap, no account changes.
The firm also set aside another $650 million for a sidecar fund. This extra cash pile gives its investors more exposure to the absolute biggest winners in the portfolio. It allows the firm to double down and increase the size of certain bets when a company shows incredible promise.
Future investments will heavily target hardware and advanced robotics
Accel has already made huge waves in the software side of artificial intelligence. It invested in Anthropic at a massive valuation last year. The firm also backed coding assistant Cursor before its overall value skyrocketed to nearly $10 billion. Because building these smart systems costs so much money, investors are increasingly willing to hand over massive sums to relatively young companies.
Going forward, the venture firm wants to look beyond just software. It plans to focus on startups that blend digital software with physical hardware. This means future massive investments will likely go toward emerging fields like advanced robotics, modern defense technology, and specialized equipment built specifically to power massive data centers.

Discussion